Rebecca E Caffrey

Title: **The Innovative Mind of Rebecca E. Caffrey**

Introduction

Rebecca E. Caffrey, an accomplished inventor based in N. Chesterfield, VA, has significantly contributed to the medical field with her innovative solutions. With a total of two patents to her name, she focuses on methods related to the detection and treatment of pancreatic dysfunction, particularly in patients who appear normoglycemic.

Latest Patents

Caffrey's latest patents include groundbreaking methods for addressing clinically significant post-prandial hyperglycemia. Her first patent details a method for detecting the likelihood of a patient developing occult pancreatic beta cell dysfunction. This method encompasses measuring the level of alpha-hydroxybutyrate (AHB) in a single fasting biological sample. By comparing this level to a reference AHB level, she can determine if the patient is at risk. An increased level of AHB indicates a potential issue in normoglycemic and normo-insulinemic patients.

The second patent focuses on a treatment method for patients identified to be at risk based on similar detection criteria. Both inventions underscore the importance of early detection and intervention in managing potential metabolic disorders.

Career Highlights

Caffrey's career is marked by her dedication to advancing medical knowledge through her patents. Working at True Health IP LLC, she has positioned herself as a leader in research related to metabolic health. Her contributions not only fill critical gaps in current medical practices but also offer patients better chances of early detection and treatment of conditions that can lead to diabetes and other metabolic disorders.

Collaborations

Throughout her journey, Rebecca E. Caffrey has collaborated with notable professionals, including her coworkers Steve Varvel and James Viktor Pottala. Their combined expertise enriches the research environment at True Health IP LLC and fosters an atmosphere of innovation.

Conclusion

Rebecca E. Caffrey exemplifies the spirit of innovation in the medical field. Her patents reflect her commitment to improving patient outcomes through scientifically rigorous methods of detection and treatment. As she continues her work at True Health IP LLC, the impact of her contributions may lead to significant advancements in the understanding and management of pancreatic health.